Thrombin generation assay - Thrombography: Methodology;Test de génération de thrombine la thrombinographie: Méthodologie

Revue Francophone des Laboratoires

Volumn 37, Issue 393, 2007, Pages 37-43

  Membré, Aurélie ^a   Wahl, Denis ^a,b   Lecompte, Thomas ^a,b   Regnault, Véronique ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Coagulation; Hemophilia; Platelet surface; Thrombin generation; Thrombophilia

Indexed keywords

EID: 34848834844     PISSN: 1773035X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-035x(07)80263-2     Document Type: Article

References (47)

1. Al Dieri R., Peyvandi F., Santagostino E., Giansily M., Mannucci P.M., Schved J.F. et al., The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding, Thromb. Haemost. 88 (2002) 576-582.
2. Alhenc-Gelas M., Plu-Bureau G., Guillonneau S., Kirzin J.M., Aiach M., Ochat N. et al., Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives, J. Thromb. Haemost. 2 (2004) 1594-1600.
3. Allen G. A., Wolberg A.S., Oliver J.A., Hoffman M., Roberts H.R., Monroe D.M., Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system, J. Thromb. Haemost. 2 (2004) 402-413.
4. Altman R., Scazziota A., De Lourdes Herrera M., Gonzalez C., Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation, J. Thromb. Haemost. 4 (2006) 2022-2027.
5. Arnout J., Vermylen J., Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease, J. Thromb. Haemost. 1 (2003) 931-942.
6. Beguin S., Keularts I., Al Dieri R., Bellucci S., Caen J., Hemker H.C., Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome, J. Thromb. Haemost. 2 (2004) 170-176.
7. Beltran-Miranda C.P., Khan A., Jaloma-Cruz A.R., Laffan M.A., Thrombin generation and phenotypic correlation in haemophilia A, Haemophilia 11 (2005) 326-334.
8. Bossuyt P.M., Lijmer J.G., Mol B.W., Randomised comparisons of medical tests: sometimes invalid, not always efficient, Lancet 356 (2000) 1844-1847.
9. Brummel-Ziedins K.E., Pouliot R.L., Mann K.G., Thrombin generation: phenotypic quantitation, J. Thromb. Haemost. 2 (2004) 281-288.
10. Brummel-Ziedins K.E., Vossen C.Y., Butenas S., Mann K.G., Rosendaal F.R., Thrombin generation profiles in deep venous thrombosis, J. Thromb. Haemost. 3 (2005) 2497-2505.
11. Butenas S., van't Veer C., Mann K.G., "Normal" thrombin generation, Blood. 94 (1999) 2169-2178.
12. Camire R.M., Kalafatis M., Simioni P., Girolami A., Tracy P.B., Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C, Blood. 91 (1998) 2818-2829.
13. Cimenti C., Koestenberger M., Leschnik B., Haidl H., Muntean W., The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT, Thromb. Res. 119 (2007) 361-367.
14. Dargaud Y., Beguin S., Lienhart A., Al Dieri R., Trzeciak C., Bordet J.C. et al., Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B, Thromb. Haemost. 93 (2005) 475-480.
15. Dargaud Y., Lienhart A., Meunier S., Hequet O., Chavanne H., Chamouard V. et al., Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision, Haemophilia 11 (2005) 552-558.
16. Dargaud Y., Luddington R., Baglin T., Platelet-dependent thrombography: a method for diagnostic laboratories, Br. J. Haematol. 134 (2006) 323-325.
17. Esmon C.T., The protein C pathway, Chest. 124 (2003) 26S-32S.
18. Giansily-Blaizot M., Al Dieri R., Schved J.F., Thrombin generation measurement in factor VII-depleted plasmas compared to inherited factor VII-deficient plasmas, Pathophysiol. Haemost. Thromb. 33 (2003) 36-42.
19. Hemker H.C., Beguin S., Phenotyping the clotting system, Thromb. Haemost. 84 (2000) 747-751.
20. Hemker H.C., Giesen P., Al Dieri R., Regnault V., de Smedt E., Wagenvoord R. et al., Calibrated automated thrombin generation measurement in clotting plasma, Pathophysiol. Haemost. Thromb. 33 (2003) 4-15.
21. Hezard N., Bouaziz-Borgi L., Remy M.G., Nguyen P., Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency, Clin. Chem. 52 (2006) 665-670.
22. Hron G., Kollars M., Binder B.R., Eichinger S., Kyrle P.A., Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation, JAMA 296 (2006) 397-402.
23. Jane S.M., Mitchell C.A., Hau L., Salem H.H., Inhibition of activated protein C by platelets, J. Clin. Invest. 83 (1989) 222-226.
24. Kessels H., Beguin S., Andree H., Hemker H.C., Measurement of thrombin generation in whole blood - the effect of heparin and aspirin, Thromb. Haemost. 72 (1994) 78-83.
25. Keularts I.M., Beguin S., de Zwaan C., Hemker H.C., Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients, Thromb. Haemost. 80 (1998) 370-371.
26. Lecompte T., Wahl D., Perret-Guillaume C., Hemker H.C., Lacolley P., Regnault V., Hypercoagulability resulting from opposite effects of lupus anticoagulant is associated strongly with thrombotic risk, Haematologica 92 (2007), sous presse.
27. Liestol S., Sandset P.M., Jacobsen E.M., Mowinckel M.C., Wisloff F., Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants, Br. J. Haematol. 136 (2007) 131-137.
28. Luddington R., Baglin T., Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition, J. Thromb. Haemost. 2 (2004) 1954-1959.
29. Macfarlane R.G., Biggs R., A thrombin generation test; the application in haemophilia and thrombocytopenia, J. Clin. Pathol. 6 (1953) 3-8.
30. Magid E., Minimal requirements for test evaluation, Scand. J. Clin. Lab. Invest. Suppl. 227 (1997) 90-94.
31. Petros S., Siegemund T., Siegemund A., Engelmann L., The effect of different anticoagulants on thrombin generation, Blood. Coagul. Fibrinolysis 17 (2006) 131-137.
32. Pitney W.R., Dacie J.V., A simple method of studying the generation of thrombin in recalcified plasma; application in the investigation of haemophilia, J. Clin. Pathol. 6 (1953) 9-14.
33. Rand M.D., Lock J.B., van't Veer C., Gaffney D.P., Mann K.G., Blood clotting in minimally altered whole blood, Blood 88 (1996) 3432-3445.
34. Regnault V., Beguin S., Lecompte T., Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability, Pathophysiol. Haemost. Thromb. 33 (2003) 23-29.
35. Regnault V., Boehlen F., Ozsahin H., Wahl D., de Groot P.G., Lecompte T. et al., Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation, J. Thromb. Haemost. 3 (2005) 1243-1249.
36. Regnault V., de Maistre E., Geschier C., Briquel M.E., André E., Stoltz J.F. et al., A new fast one-step immunopreparation for activated protein C, Thromb. Haemost. 13 (1995) 1365.
37. Regnault V., Hemker H.C., Wahl D., Lecompte T., Phenotyping the haemostatic system by thrombography-potential for the estimation of thrombotic risk, Thromb. Res. 114 (2004) 539-545.
38. Reverter J.C., Beguin S., Kessels H., Kumar R., Hemker H.C., Coller B.S., Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis", J. Clin. Invest. 98 (1996) 863-874.
39. Rosing J., Tans G., Nicolaes G.A., Thomassen M.C., van Oerle R., van der Ploeg P.M. et al., Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives, Br. J. Haematol. 97 (1997) 233-238.
40. Rotteveel R.C., Roozendaal K.J., Eijsman L., Hemker H.C., The influence of oral contraceptives on the time-integral of thrombin generation (thrombin potential), Thromb. Haemost. 70 (1993) 959-962.
41. Safa O., Hensley K., Smirnov M.D., Esmon C.T., Esmon N.L., Lipid oxidation enhances the function of activated protein C, J. Biol. Chem. 276 (2001) 1829-1836.
42. Siegemund T., Petros S., Siegemund A., Scholz U., Engelmann L., Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma, Thromb. Haemost. 90 (2003) 781-786.
43. Simioni P., Castoldi E., Lunghi B., Tormene D., Rosing J., Bernardi F., An underestimated combination of opposites resulting in enhanced thrombotic tendency, Blood 106 (2005) 2363-2365.
44. Tans G., van Hylckama Vlieg A., Thomassen M.C., Curvers J., Bertina R.M., Rosing J. et al., Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women, Br. J. Haematol. 122 (2003) 465-470.
45. Taube J., McWilliam N., Luddington R., Byrne C.D., Baglin T., Activated protein C resistance: effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteins, Blood 93 (1999) 3792-3797.
46. Varadi K., Turecek P.L., Schwarz H.P., Thrombin generation assay and other universal tests for monitoring haemophilia therapy, Haemophilia 10 (Suppl 2) (2004) 17-21.
47. Wagenvoord R.J., Hendrix H.H., Kai H., Hemker H.C., A chromogenic test to determine the procoagulant phospholipids in platelet-rich plasma and whole blood, Thromb. Haemost. 72 (1994) 582-587.